久久一区二区三区四区_欧美高清dvd_日韩欧美在线看_国产精品欧美一区二区_av天天看_欧美精品免费观看二区

艾伯維  AbbVie  
 雅培（Abbott） 將品牌藥業務拆分組建新公司Abbvie的計劃。Abbvie將作為一個獨立的公司，于2013年1月2日在紐約證券交易所交易，股票符號為ABBV。雅培將保留其醫療設備、診斷、營養品業務，以及專利到期的藥物

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and capabilities of a long-established pharmaceutical leader to develop and market advanced therapies that address some of the world’s most complex and serious diseases. In 2013, AbbVie will employ approximately 21,000 people worldwide and markets medicines in more than 170 countries.